Compare Edwards Lifesciences Corporation Common Stock (EW) vs Lemonade Inc (LMND) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Lemonade Inc — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while Lemonade Inc trades at $47.15 (market cap $3.62B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 13.7× Lemonade Inc's market cap, and Edwards Lifesciences Corporation Common Stock is trading nearer its 52-week high, Lemonade Inc nearer its low. Which is the better fit depends on your goals.
| EW | LMND | |
|---|---|---|
Market Cap | $49.44B | $3.62B |
Volume | 3,508,027 | 1,002,548 |
Sector | Health | Financials |
52-Week High | $95.18 | $96.57 |
52-Week Low | $72.65 | $43.91 |
Enterprise Value | $45.90B | $3.48B |
Typical Hold Time | — | 27 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Lemonade (LMND) trades at $46.91, up 1.32% with bearish technical signals despite recent earnings beats. The company shows strong revenue growth from $257M in 2022 to $738M in 2025, though remains unprofitable with a -22.43% net margin. Recent expansion into Alaska and Kentucky, coupled with AI-driven efficiency improvements, supports management's target of EBITDA profitability by late 2026.
While growth prospects remain compelling with a $67 consensus price target, investors face significant execution risk as the company burns cash and faces intense insurance competition. The path to profitability remains the critical factor for shareholder returns, with current valuation at 3.63x sales reflecting growth expectations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Lemonade Inc
Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes.
Read more on LMND →
